HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

A leader of the 2014 U.S. Ebola response compares then to now

As the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded Aid Transition Alliance to support former USAID professionals, discusses the...

By STAT News · Jun 9, 2026 · via STAT News
A leader of the 2014 U.S. Ebola response compares then to now

Image: STAT News

This is an aggregated industry headline. Read the full story at STAT News →

Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
The WeekFiercePharma ↗
The Oral GLP-1 Tracker: Novo's oral Wegovy hits 3M prescription milestone as Lilly's Foundayo chugs along in early launch
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…
Jun 9, 2026
Bial bails after Parkinson's fail, axing asset over phase 2 miss
The WeekFierceBiotech ↗
Bial bails after Parkinson's fail, axing asset over phase 2 miss
Bial has stopped development in a subpopulation of Parkinson's disease patients after its phase 2b trial misse…
Jun 9, 2026
ResMed buys Noctrix Health for $340M, widening its sleep-tech reach
The WeekBriefing
ResMed buys Noctrix Health for $340M, widening its sleep-tech reach
The sleep and respiratory giant completed the $340M Noctrix acquisition, adding a wearable neuromodulation tre…
Jun 9, 2026